Web-based International Register of Emergency Surgery and Trauma (WIRES-T)
Study Overview
Status
Status
Conditions
Conditions
- Trauma
- Abdominal Wall Hernia
- Acute Pancreatitis
- Intestinal Ischemia
- Acute Cholecystitis
- Acute Appendicitis
- Acute Diverticulitis
- Foreign Bodies
- Post-operative Complications
- Perforated Gastro-duodenal Ulcers
- Adhesive Small Bowell Occlusion
- Colonic Neoplastic Emergencies
- Gynecological Emergencies
- Vascular Emergencies
- Caustic Ingestion
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Federico Coccolini, MD
- Phone Number: 0039-050996123
- Email: federico.coccolini@gmail.com
Study Locations
-
-
-
Pisa, Italy
- Recruiting
- General, Emergency and Trauma surgery, University Hospital of Pisa
-
Contact:
- Federico Coccolini, MD
- Phone Number: 050-996123
- Email: federico.coccolini@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients affected by an acute surgical disease
- Patients with indication to be referred to the emergency surgeon attention
- Patients to be operated or to be treated with non-operative approach without surgical intervention
Exclusion Criteria:
- Patients not affected by an acute surgical disease
- Patients without indication to be referred to the emergency surgeon attention
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate of patients treated with surgery
Time Frame: Until hospital discharge, approximately 2 weeks
|
Evaluate the rate of operative treatment for each different disease according to the different enviroment; for each intervention the surgical approach (laparotomic, mini-invasive, laparoscopic) will be evaluated.
|
Until hospital discharge, approximately 2 weeks
|
|
Rate of patients treated with conservative treatment
Time Frame: Until hospital discharge, approximately 2 weeks
|
Evaluate the conservative treatment rate for each different disease according to patient's characteristics and the enviroinment.
|
Until hospital discharge, approximately 2 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: Until hospital discharge, approximately 2 weeks
|
To evaluate the differences in mortality rate linked to the different managements, techniques, environments and patient variables.
|
Until hospital discharge, approximately 2 weeks
|
|
Morbidity
Time Frame: Until hospital discharge, approximately 2 weeks
|
To evaluate the differences in morbidity rate linked to the different managements, techniques, environments and patient variables.
|
Until hospital discharge, approximately 2 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Digestive System Diseases
- Pathologic Processes
- Infections
- Disease Attributes
- Gastrointestinal Diseases
- Stomach Diseases
- Gastroenteritis
- Intestinal Diseases
- Pathological Conditions, Anatomical
- Duodenal Diseases
- Gallbladder Diseases
- Biliary Tract Diseases
- Pancreatic Diseases
- Cecal Diseases
- Diverticular Diseases
- Hernia
- Intraabdominal Infections
- Emergencies
- Wounds and Injuries
- Cholecystitis
- Cholecystitis, Acute
- Postoperative Complications
- Hernia, Ventral
- Appendicitis
- Diverticulitis
- Pancreatitis
- Duodenal Ulcer
- Hernia, Abdominal
- Internal Hernia
- Peptic Ulcer
- Foreign Bodies
Other Study ID Numbers
Other Study ID Numbers
- FC-001-2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
NCT05873959CompletedTrauma | Trauma Injury | Trauma, Multiple | Trauma Blunt
-
NCT06402669CompletedTrauma Injury | Trauma Blunt | Vascular Trauma
-
NCT05175872CompletedTrauma Injury | Trauma, Multiple
-
NCT04993495Recruiting
-
NCT05441787CompletedTrauma Injury | Trauma, Multiple
-
NCT07208110RecruitingTrauma Injury | Trauma Patients in ICU | Trauma (Including Fractures) | Trauma Patients | Trauma ICU Patients
-
NCT06305819RecruitingTrauma Injury | Trauma, Multiple | Polytrauma
-
NCT01534117CompletedHead Injury Trauma Blunt
Clinical Trials on Emergency General Surgery
-
NCT04450277CompletedCOVID-19 | Emergency Surgery
-
NCT02825082Completed
-
NCT02179112Completed
-
NCT03582631CompletedInflammation | Biomarkers | General Surgery | Troponins
-
NCT05153031CompletedAcute Cholecystitis | Percutaneous Cholecystostomy